Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00002707
What this trial is testing

Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed

Who this might be right for
Breast Cancer
NSABP Foundation Inc 2,411
Testing effectiveness (Phase 2)Study completedNCT00035607
What this trial is testing

Chemotherapy Related Anemia

Who this might be right for
AnemiaNon-Myeloid Malignancies
Amgen 120
Large-scale testing (Phase 3)Ended earlyNCT02532400
What this trial is testing

Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients

Who this might be right for
Breast Cancer
Ruijin Hospital 21
Testing effectiveness (Phase 2)Study completedNCT00807911
What this trial is testing

Adjuvant Chemotherapy After Preoperative Chemoradiotherapy to Treat Rectal Cancer

Who this might be right for
Rectal Cancer
Asan Medical Center 322
Early research (Phase 1)Study completedNCT03393611
What this trial is testing

CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, AcuteLeukemia, Relapsed Adult Acute Myeloid+1 more
Weill Medical College of Cornell University 14
Testing effectiveness (Phase 2)Study completedNCT00000811
What this trial is testing

Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children

Who this might be right for
Bacterial InfectionsPneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 690
Testing effectiveness (Phase 2)Study completedNCT03562871
What this trial is testing

IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC

Who this might be right for
NSCLC
IO Biotech 109
Testing effectiveness (Phase 2)Study completedNCT01160744
What this trial is testing

Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company 280
Early research (Phase 1)Study completedNCT02051335
What this trial is testing

Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults

Who this might be right for
Memory ImpairmentAlzheimer's Disease
AstraZeneca 27
Testing effectiveness (Phase 2)Ended earlyNCT00321308
What this trial is testing

Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
Pfizer 36
Not applicableUnknownNCT01814150
What this trial is testing

The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel

Who this might be right for
Metastatic Lung CancerMetastatic Breast CancerMetastatic Gastric Cancer+2 more
Gottfried Maya 200
Testing effectiveness (Phase 2)Looking for participantsNCT06368817
What this trial is testing

Lower Radiotherapy Dose to Treat Children With CNS Germinoma

Who this might be right for
Basal Ganglia GerminomaDiabetes InsipidusGerminoma+3 more
Children's Oncology Group 240
Not applicableNot Yet RecruitingNCT07791550
What this trial is testing

Baduanjin for Quality of Life in Pancreatic Cancer Chemotherapy

Who this might be right for
Pancreatic NeoplasmsPancreatic CancerDrug-Related Side Effects and Adverse Reactions (MeSH Term)
Tianjin Medical University Cancer Institute and Hospital 96
Testing effectiveness (Phase 2)UnknownNCT03985891
What this trial is testing

The Efficacy of JS001 Combined With Chemotherapy in Patients With Locally Advanced Colon Cancer

Who this might be right for
Colonic NeoplasmsChemotherapy Effect
Xiangya Hospital of Central South University 40
Testing effectiveness (Phase 2)Study completedNCT00002608
What this trial is testing

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Who this might be right for
Adrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck Cancer+4 more
Ottawa Regional Cancer Centre 30
Early research (Phase 1)Looking for participantsNCT05911217
What this trial is testing

Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
CARsgen Therapeutics Co., Ltd. 20
Large-scale testing (Phase 3)UnknownNCT02817425
What this trial is testing

A Efficacy and Tolerability Study of TEGAFOX Sequential S-1 in the Treatment of Adjuvant Chemotherapy for Gastric Cancer

Who this might be right for
Gastric Cancer
LanZhou University 300
Early research (Phase 1)Study completedNCT02382640
What this trial is testing

Effect of Antacid on Bioavailability of Febuxostat After Administration of a Febuxostat 80 mg Extended-Release Capsule

Who this might be right for
Healthy Volunteers
Takeda 36
Large-scale testing (Phase 3)Study completedNCT00002568
What this trial is testing

Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer

Who this might be right for
Ovarian Cancer
Gynecologic Oncology Group 470
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07107217
What this trial is testing

Camrelizumab in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-negative Breast Cancer

Who this might be right for
Breast Cancer
Blokhin's Russian Cancer Research Center 40
Next Page